
Ionis Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report
Description
Ionis Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report
Summary
Ionis Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ionis Pharmaceuticals, Inc. (Ionis or ‘the company’) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s, and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. The company primarily operates in the US. The company is headquartered in Carlsbad, California, the US.
Scope
Summary
Ionis Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ionis Pharmaceuticals, Inc. (Ionis or ‘the company’) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s, and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. The company primarily operates in the US. The company is headquartered in Carlsbad, California, the US.
Scope
- Detailed information on Ionis Pharmaceuticals, Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc in the form of a SWOT analysis
- An in-depth view of the business model of Ionis Pharmaceuticals, Inc including a breakdown and examination of key business segments
- Intelligence on Ionis Pharmaceuticals, Inc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ionis Pharmaceuticals, Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Ionis Pharmaceuticals, Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ionis Pharmaceuticals, Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Ionis Pharmaceuticals, Inc's business structure, strategy and prospects.
Table of Contents
55 Pages
- Company Snapshot
- Ionis Pharmaceuticals, Inc.: Company Overview
- Ionis Pharmaceuticals, Inc.: Overview and Key Facts
- Ionis Pharmaceuticals, Inc.: Overview
- Ionis Pharmaceuticals, Inc.: Key Facts
- Ionis Pharmaceuticals, Inc.: Key Employees
- Ionis Pharmaceuticals, Inc.: Key Employee Biographies
- Ionis Pharmaceuticals, Inc.: Major Products and Services
- Ionis Pharmaceuticals, Inc.: Company History
- Ionis Pharmaceuticals, Inc.: Management Statement
- Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
- Ionis Pharmaceuticals, Inc.: Key Competitors
- Ionis Pharmaceuticals, Inc.: Company Analysis
- Ionis Pharmaceuticals, Inc.: Business Description
- Ionis Pharmaceuticals, Inc.: SWOT Analysis
- Ionis Pharmaceuticals, Inc.: SWOT Overview
- Ionis Pharmaceuticals, Inc.: Strengths
- Ionis Pharmaceuticals, Inc.: Weaknesses
- Ionis Pharmaceuticals, Inc.: Opportunities
- Ionis Pharmaceuticals, Inc.: Threats
- Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity
- Ionis Pharmaceuticals, Inc.: Financial Deals Overview
- Ionis Pharmaceuticals, Inc.: Targets and Partners
- Ionis Pharmaceuticals, Inc.: Top Deals 2018 - 2022YTD*
- Ionis Pharmaceuticals, Inc.: Advisors
- Ionis Pharmaceuticals, Inc.: Top Legal Advisors
- Ionis Pharmaceuticals, Inc.: Top Financial Advisors
- Ionis Pharmaceuticals, Inc.: Mergers and Acquisitions
- Ionis Pharmaceuticals, Inc.: Corporate Venturing
- Ionis Pharmaceuticals, Inc.: Capital Raising
- Ionis Pharmaceuticals, Inc.: Partnership
- Ionis Pharmaceuticals, Inc.: Recent Developments
- Ionis Pharmaceuticals, Inc.: News and Events Summary
- Ionis Pharmaceuticals, Inc.: Business Expansion
- Ionis Pharmaceuticals, Inc.: Corporate Governance
- Ionis Pharmaceuticals, Inc.: Financial Performance
- Ionis Pharmaceuticals, Inc.: Market Developments
- Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
- Ionis Pharmaceuticals, Inc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: Ionis Pharmaceuticals, Inc.: Key Facts
- Table 2: Ionis Pharmaceuticals, Inc.: Key Employees
- Table 3: Ionis Pharmaceuticals, Inc.: Company History
- Table 4: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
- Table 5: Ionis Pharmaceuticals, Inc.: Key Competitors
- Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 7: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Table 8: Ionis Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
- Table 9: Ionis Pharmaceuticals, Inc.: Targets and Partners
- Table 10: Ionis Pharmaceuticals, Inc.: Top Deals 2018 - 2022YTD*
- Table 11: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 12: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 13: Ionis Pharmaceuticals, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
- Table 14: Ionis Pharmaceuticals, Inc.: M&A Activity by Geography (2018 - YTD*2022)
- Table 15: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
- Table 16: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
- Table 17: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
- Table 18: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
- Table 19: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
- Table 20: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
- Table 21: Ionis Pharmaceuticals, Inc.: News and Events Summary
- Table 22: Ionis Pharmaceuticals, Inc.: Business Expansion
- Table 23: Ionis Pharmaceuticals, Inc.: Corporate Governance
- Table 24: Ionis Pharmaceuticals, Inc.: Financial Performance
- Table 25: Ionis Pharmaceuticals, Inc.: Market Developments
- Table 26: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
- Table 27: Ionis Pharmaceuticals, Inc.: Strategy and Operations
- List of Figures
- Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Figure 3: Ionis Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
- Figure 4: Ionis Pharmaceuticals, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
- Figure 5: Ionis Pharmaceuticals, Inc.: M&A Activity by Geography (2018 - YTD*2022)
- Figure 6: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
- Figure 7: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
- Figure 8: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
- Figure 9: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
- Figure 10: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
- Figure 11: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.